Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 7 - Number 1

Author Index To Volume 6

, 7(1): iii

Bentham Science Publishers


DOI: 10.2174/1871530310707010iii




Subject Index To Volume 6

, 7(1): x

Bentham Science Publishers


DOI: 10.2174/187153031070701000x




Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?

, 7(1): 1 - 5

M. E. Baldassarre, M. A. Altomare, M. Fanelli, D. Carbone, G. Di Bitonto, A. Mautone and N. Laforgia


DOI: 10.2174/187153007780059441




Chemokines as Drug Targets in Type 1 Diabetes

, 7(1): 7 - 12

Urs Christen


DOI: 10.2174/187153007780059405




Epigenetic Alterations of the Wnt/β -Catenin Pathway in Human Disease

, 7(1): 13 - 21

Oscar Aguilera, Alberto Munoz, Manel Esteller and Mario F. Fraga


DOI: 10.2174/187153007780059450




CD40L - A Multipotent Molecule for Tumor Therapy

, 7(1): 23 - 28

Angelica Loskog and Thomas H. Totterman


DOI: 10.2174/187153007780059432




Use of Systemic Proteasome Inhibition as an Immune-Modulating Agent in Disease

, 7(1): 29 - 34

Lauren H. Mattingly, Ruth A. Gault and William J. Murphy


DOI: 10.2174/187153007780059397




Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006

, 7(1): 35 - 63

C. Kleinschnitz, S. G. Meuth, B. C. Kieseier and H. Wiendl


DOI: 10.2174/187153007780059414




Role of Insulin in the Pathogenesis of Free Fatty Acid-Induced Insulin Resistance in Skeletal Muscle

, 7(1): 65 - 74

Jianping Ye


DOI: 10.2174/187153007780059423




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science